Skip to main content
Livermore
Livermore
ZHEN

Centaurus Financial, Inc.

SEC CIK
0000891943
Latest filing
Aug 17, 2026

GSK holding history

GSK plc in every 13F filed by Centaurus Financial, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
2,475
Value
$130.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Centaurus Financial, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,475$130.0K<0.1%−37−1.5%ReducedHolders
Q1 20262,512$139.0K<0.1%+6+0.2%AddedHolders
Q4 20252,506$123.0K<0.1%−6,943−73.5%ReducedHolders
Q3 20259,449$408.0K<0.1%+6,355+205.4%AddedHolders
Q2 20253,094$119.0K<0.1%−137−4.2%ReducedHolders
Q1 20253,231$125.0K<0.1%−919−22.1%ReducedHolders
Q4 20244,150$140.0K<0.1%−111−2.6%ReducedHolders
Q3 20244,261$174.0K<0.1%−254−5.6%ReducedHolders
Q2 20244,515$174.0K<0.1%−1,830−28.8%ReducedHolders
Q1 20246,345$272.0K<0.1%−1,866−22.7%ReducedHolders
Q4 20238,211$304.0K<0.1%+67+0.8%AddedHolders
Q3 20238,144$295.0K<0.1%+1,127+16.1%AddedHolders
Q2 20237,017$250.0K<0.1%−1,792−20.3%ReducedHolders
Q1 20238,809$313.0K<0.1%−904−9.3%ReducedHolders
Q4 20229,713$341.0K<0.1%−256−2.6%ReducedHolders
Q3 20229,969$293.0K<0.1%−3,487−25.9%ReducedHolders
Q2 202213,456$586.0K0.1%−30−0.2%ReducedHolders
Q1 202213,486$587.0K<0.1%−945−6.5%ReducedHolders
Q4 202114,431$636.0K<0.1%+614+4.4%AddedHolders
Q3 202113,817$528.0K<0.1%−424−3.0%ReducedHolders
Q2 202114,241$567.0K<0.1%+4,479+45.9%AddedHolders
Q1 20219,762$348.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.